SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced it is offering no-cost feature updates for t:slim X2 ...

The US Food and Drug Administration (FDA) has granted clearance for the Android version of Tandem Diabetes Care’s Tandem Mobi ...

* Intends to roll out Tandem device updater first to early t:slim pump users throughout summer in a series of test groups * Tandem Diabetes says plans expanded launch for Tandem device later this year ...

The technology went through the FDA’s new interoperability pathway, which encourages device-makers to build products that can be used across systems or platforms. Both Tandem Diabetes’ software and ...

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received FDA approval for the Android version of its Mobi mobile app.

CHICAGO, Dec 13 (Reuters) - The U.S. Food and Drug Administration on Friday granted approval for Tandem Diabetes Care's TNDM.O software program that uses readings from a continuous glucose monitor to ...

Insulin pumps are already used by more than a third of all people with Type 1 diabetes in the U.S., according to Elizabeth Gasser, an executive vice president at Tandem and its chief strategy ...

At least 224 diabetes patients have been harmed by a software error causing their insulin pumps to spontaneously shut down, the Food and Drug Administration announced ...

More than 200 people with diabetes were injured when their insulin pumps shut down unexpectedly due to a problem with a connected mobile app, the US Food and Drug Administration said Wednesday.

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced U.S. Food and Drug Administration (FDA) clearance of ...